These results indicate that Ad-ATF/SOX2 shows an antitumor effect more strongly than Ad-shSOX2 in all the SOX2 positive lung and esophageal SCC cells indicated. This evidence concerns the gene SOX2 and esophageal squamous cell carcinoma.